Novo Nordisk (NYSE:NVO) is introducing NovoCare Pharmacy, a direct-to-patient delivery option offering Wegovy at a reduced price of $499 per month for certain cash-paying patients.

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss: How ...

Bernstein analysts told investors in a note Tuesday that Eli Lilly (NYSE: LLY) is gaining ground in the GLP-1 market, edging ...

We recently published a list of Top 10 AI Stocks Analysts Are Monitoring. In this article, we are going to take a look at ...

Asceneuron is the latest biotech to face setbacks in developing tau-targeting therapies for Alzheimer’s. After Eli Lilly and ...

Shares of Hims and Hers (NYSE: HIMS) fell 3% amidst news of Novo Nordisk (NYSE: NVO) introducing NovoCare Pharmacy, which directly impacts the competitive landsca ...

We recently compiled a list of the 10 Cash-Rich Small Cap Stocks To Invest In According To Analysts. In this article, we are going to take a look at where LiveRamp Holdings ... where strong economic ...

Novo Holdings' $16.5 billion acquisition of US ... Alongside the acquisition, Novo Nordisk has also embarked on a major capital investment programme to build manufacturing capacity in Europe ...

It is connected to a larger transaction in which Novo Nordisk’s controlling shareholder Novo Holdings will buy Catalent ... The decision to make such a huge investment in its manufacturing ...

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Operator Welcome to BioNTech's fourth quarter and full year 2024 earnings call. I would like to hand the call over to Michael ...

Stock futures are little changed Wednesday night after the major averages rebounded on hopes for concessions on President ...